Dr Mark Richardson is CEO at the National Biofilms Innovation Centre (NBIC).
Mark joined NBIC on its formation in December 2017. Mark worked for over 30 years in R&D in the Medical Device Industry, leading projects and global teams. He led the Global Innovation team for Smith & Nephew Wound Management from 2000-2002, and then formed and led their approaches to Open Innovation, including engaging with Innovation Knowledge Centres in the UK.
Mark gained his degree in Microbiology at the University of Leeds followed by an MSc and PhD in Biochemistry from the University of Birmingham. He also has an MBA from the Open University.